Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
NOVOLIN R insulin (regular human insulin) is an injectable medication prescribed for people with type 1 or type 2 diabetes mellitus. NOVOLIN R is injected under the skin with a short needle in the abdomen, back up the upper arm, or the front and outer sides of the thighs.
People with diabetes mellitus cannot regulate their blood sugar, and it may be too high or too low. High blood sugar can cause long-term damage to organs, and low blood sugar can be life-threatening. NOVOLIN R helps to regulate glycemic control.
Administer NOVOLIN R subcutaneously between one and three times daily as directed by the prescriber. NOVOLIN R should be injected approximately 30 minutes before a meal. Do not skip a meal after injecting NOVOLIN R.
The active ingredient in NOVOLIN R is regular human insulin.
Tell your doctor or pharmacist if you use any of the following medications:
These medications can raise or lower blood sugar and may require that the dose of insulin be adjusted.
Monitor blood sugar frequently while using insulin therapy to prevent blood sugar from becoming too high or low.
Your doctor should monitor potassium levels while taking NOVOLIN R.
Your doctor should monitor your kidney and liver function while using NOVOLIN R.
Common adverse reactions to NOVOLIN R may include:
Novolin R [package insert] Princeton, NJ: Novo Nordisk; 2012.